Using Biomarkers to Inform Cumulative Risk Assessment
2007

Using Biomarkers to Inform Cumulative Risk Assessment

publication Evidence: moderate

Author Information

Author(s): Ryan P. Barry, Burke Thomas A., Cohen Hubal Elaine A., Cura Jerome J., McKone Thomas E.

Primary Institution: Rollins School of Public Health, Emory University

Hypothesis

Can biomarkers enable us to understand and quantify better the population burden of disease and health effects attributable to environmental exposures?

Conclusion

Biomarkers can help infer the source and magnitude of exposure among competing sources and pathways, improving our understanding of health risks.

Supporting Evidence

  • Biomarkers can disaggregate health effects into specific risk factors.
  • An array of biomarkers provides a better understanding of cumulative exposure.
  • Biomarkers of exposure, effect, and susceptibility are essential for assessing health risks.
  • Case studies illustrate the application of biomarkers in understanding environmental health impacts.

Takeaway

Biomarkers are like clues that help scientists figure out how pollution affects our health. They can show us where the pollution comes from and how it makes us sick.

Methodology

A case-study approach was used to evaluate the role of biomarkers in assessing cumulative health risks from environmental exposures.

Limitations

The association between many biomarkers and health outcomes is not direct due to variability in sensitivity and susceptibility among individuals.

Digital Object Identifier (DOI)

10.1289/ehp.9334

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication